Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

On remand from the U.S. Court of Appeals for the Federal Circuit (CAFC), the Patent Trial and Appeal Board (PTAB) on Thursday reaffirmed its decision that The Broad Institute, Inc., Massachusetts ...